Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
Yao, James C, Dr, Fazio, Nicola, MD, Singh, Simron, MD, Buzzoni, Roberto, MD, Carnaghi, Carlo, MD, Wolin, Edward, MD, Tomasek, Jiri, MD, Raderer, Markus, MD, Lahner, Harald, MD, Voi, Maurizio, MD, Pacaud, Lida Bubuteishvili, MD, Rouyrre, Nicolas, MSc, Sachs, Carolin, RN, Valle, Juan W, MD, Fave, Gianfranco Delle, MD, Van Cutsem, Eric, MD, Tesselaar, Margot, MD, Shimada, Yasuhiro, MD, Oh, Do-Youn, MD, Strosberg, Jonathan, MD, Kulke, Matthew H, MD, Pavel, Marianne E, MD
Published in The Lancet (British edition) (05.03.2016)
Published in The Lancet (British edition) (05.03.2016)
Get full text
Journal Article